Featured Posts
Blog
Fauci’s lasting legacy will be the damage he did to science and government
Anthony Fauci isn’t faring well in the court of public opinion. His recently divulged “diary” and subsequent July 29 appearance before the Senate Homeland…
News Release
FDA commissioner resignation opens opportunity for refocus on science over politics
After a somewhat tumultuous tenure, FDA commissioner Marty Makary is stepping down. While Dr. Makary made his mission to accelerate drug approval and bring…
Blog
Don’t hinder biosimilar development
In its most recent legislative session, the Florida legislature considered precluding pharmacy benefit managers (PBMs) from holding an investment interest in biosimilar manufacturing.
Search Posts
DC Journal
What the Media Gets Wrong About Medicaid ‘Cuts’
Headlines assert that the reforms Republicans recently passed amount to a trillion-dollar cut to Medicaid. The New York Times calls this the most significant cut to…
Blog
Free the Economy podcast: Alcohol labels and warnings with David Clement
In this week’s episode we cover housing abundance in California, the meaning of a market economy, union privileges for government…
News Release
Senate Big Beautiful Bill Contains Needed Medicaid Reforms
The Senate today voted 51 to 50 to pass the Reconciliation package known as the “One Big Beautiful Bill,” following House passage in…
Blog
FDA can’t stomach fluoride and doesn’t want you to, either
On May 13, the Food and Drug Administration (FDA) announced that it would begin a process intended to exclude ingestible prescription fluoride products…
Blog
The MAHA Report is a missed opportunity
Less than six months into the new administration, the Department of Health and Human Services (HHS) has produced its Make Our Children Healthy…
Blog
CBO likely overestimates effects of Medicaid reforms
Yesterday, the Congressional Budget Office (CBO) released its estimates of the costs, both financial and in coverage, of the One Big Beautiful Bill…